Evidence from current practice provided by NHS England and analysed by NICE indicates that digital therapies recommended for PTSD could save over 5,000 hours of therapist time per 1,000 people. Almost ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Comparator companies Accord Healthcare (donepezil, memantine) (confidentiality agreement not signed, not participating) Accord-UK (donepezil, galantamine, memantine) (confidentiality agreement not ...

You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...

All NICE products on lipid disorders. Includes any guidance and quality standards.

Empagliflozin for treating type 2 diabetes in people 10 to 17 years (terminated appraisal) TA1006 12 September 2024 12 September 2024 Evinacumab for treating homozygous familial hypercholesterolaemia ...

NICE has recommended belzutifan for some adults with Von Hippel-Lindau disease, in final draft guidance, which could benefit ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Our quality standards play a key role in helping commissioners and providers. They can: support in identifying changes that need to be made in order to develop services empower providers to ask for ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

There is a simple discount patient access scheme for rucaparib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...